2014
DOI: 10.1016/j.jsbmb.2014.08.008
|View full text |Cite
|
Sign up to set email alerts
|

Molecular determinants of the recognition of ulipristal acetate by oxo-steroid receptors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
25
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 40 publications
(27 citation statements)
references
References 61 publications
2
25
0
Order By: Relevance
“…The corepressor peptide binds to the AF-2 surface through interactions with helix 3 and helix 4/5, but unlike the active conformation the peptide does not contact helix 12. As observed in other crystal structures of corepressor-peptide-bound NR LBDs [3][4][5][6][7][8][9][11][12][13][14] , there is an extension of the corepressor peptide by one helical turn relative to the coactivator peptide that would physically clash with helix 12 in the active conformation. Instead, helix 12 occupies the orthosteric ligand-binding pocket overlapping with the active conformation rosiglitazone orthosteric binding mode (Fig.…”
Section: Crystal Structures Of the Repressive Conformation Of Pparγsupporting
confidence: 60%
See 1 more Smart Citation
“…The corepressor peptide binds to the AF-2 surface through interactions with helix 3 and helix 4/5, but unlike the active conformation the peptide does not contact helix 12. As observed in other crystal structures of corepressor-peptide-bound NR LBDs [3][4][5][6][7][8][9][11][12][13][14] , there is an extension of the corepressor peptide by one helical turn relative to the coactivator peptide that would physically clash with helix 12 in the active conformation. Instead, helix 12 occupies the orthosteric ligand-binding pocket overlapping with the active conformation rosiglitazone orthosteric binding mode (Fig.…”
Section: Crystal Structures Of the Repressive Conformation Of Pparγsupporting
confidence: 60%
“…Agonist binding to the NR orthosteric ligand-binding pocket stabilizes the C-terminal structural element in the LBD, helix 12, in an active conformation that facilitates binding of LXXLL-containing motifs present in transcriptional coactivator proteins. In contrast, structural studies available for only a few NRs have not revealed a unified mechanism for repression of NR transcription [3][4][5][6][7][8][9][10][11][12][13][14] , suggesting that corepressor-dependent transcriptional repression of NRs occurs through structurally diverse mechanisms. Furthermore, the conformational ensemble of helix 12 in apo-NR LBDs, which is hypothesized to exchange between a transcriptionally active conformation and a repressive conformation, remains poorly defined.…”
mentioning
confidence: 96%
“…1). Lysates were also incubated with [ 3 H]cortisol plus 500-fold excess of RU486, which was unable to bind MRs (30). As expected, RU486 displaced [ 3 H]cortisol binding from GRs, but not from MRs (Supplemental Fig.…”
Section: Validation Of Cellular and Molecular Toolsmentioning
confidence: 52%
“…Taking the crystal antagonistic structure models (PDB ID 2OVH, Fig 1B) as an example, helix 12 is displaced from the surface of the LBD core and is antiparallel to helix 11, while the co-peptides (12 residues), which are a the common sequences in NCoR peptide (25 residues), occupy the hydrophobic groove formed by helix 3 and helix 4. The antagonists of PR LBD bind to the same binding pocket as progesterone does, whereas the unusually large 11β-substituted group of some antagonists prevent helix 12 from contacting with helix 3 [19,20]. In more detail, the antagonist 11β-substituted group adopts the conformational space where Met908 and Met909 in helix 12 used to take, therefore it was believed the relatively large size of 11β-substituted group contributes to the antagonistic conformation [19].…”
Section: Introductionmentioning
confidence: 99%